BRPI0812064A2 - Formulação farmacêutica, tabletes, e, processo para a produção de uma formulação farmacêutica - Google Patents

Formulação farmacêutica, tabletes, e, processo para a produção de uma formulação farmacêutica

Info

Publication number
BRPI0812064A2
BRPI0812064A2 BRPI0812064-1A2A BRPI0812064A BRPI0812064A2 BR PI0812064 A2 BRPI0812064 A2 BR PI0812064A2 BR PI0812064 A BRPI0812064 A BR PI0812064A BR PI0812064 A2 BRPI0812064 A2 BR PI0812064A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
tables
production
formulation
pharmaceutical
Prior art date
Application number
BRPI0812064-1A2A
Other languages
English (en)
Inventor
Karl Kolter
Michael Schoenherr
Silke Gebert
Kathrin Meyer-Boehm
Angelika Maschke
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of BRPI0812064A2 publication Critical patent/BRPI0812064A2/pt
Publication of BRPI0812064B1 publication Critical patent/BRPI0812064B1/pt
Publication of BRPI0812064B8 publication Critical patent/BRPI0812064B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
BRPI0812064A 2007-06-06 2008-06-03 formulação farmacêutica na forma de aglomerados, comprimidos, e, processo para a produção de uma formulação farmacêutica BRPI0812064B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109722 2007-06-06
PCT/EP2008/056805 WO2008148742A2 (de) 2007-06-06 2008-06-03 Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten

Publications (3)

Publication Number Publication Date
BRPI0812064A2 true BRPI0812064A2 (pt) 2014-11-25
BRPI0812064B1 BRPI0812064B1 (pt) 2019-08-13
BRPI0812064B8 BRPI0812064B8 (pt) 2021-05-25

Family

ID=39643971

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812064A BRPI0812064B8 (pt) 2007-06-06 2008-06-03 formulação farmacêutica na forma de aglomerados, comprimidos, e, processo para a produção de uma formulação farmacêutica

Country Status (11)

Country Link
US (1) US10406105B2 (pt)
EP (1) EP2164462B1 (pt)
JP (2) JP5627455B2 (pt)
KR (2) KR101903781B1 (pt)
CN (1) CN101707930B (pt)
AU (1) AU2008258627A1 (pt)
BR (1) BRPI0812064B8 (pt)
CA (1) CA2686964A1 (pt)
ES (1) ES2639130T3 (pt)
MX (1) MX2009013063A (pt)
WO (1) WO2008148742A2 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
JP2010529071A (ja) * 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性錠剤製造のための医薬製剤
KR101903781B1 (ko) * 2007-06-06 2018-11-13 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
CN102988318A (zh) * 2008-11-25 2013-03-27 田边三菱制药株式会社 口腔速崩片及其制备方法
AR074689A1 (es) * 2008-12-19 2011-02-02 Solvay Pharm Bv Formulaciones farmaceuticas de desintegracion rapida pre-compactadas de compuestos con baja biodisponibilidad oral. proceso de preparacion
TWI455733B (zh) * 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
JPWO2010119851A1 (ja) * 2009-04-14 2012-10-22 ライオン株式会社 口腔内崩壊錠
JP6073543B2 (ja) * 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
KR102435108B1 (ko) 2010-08-04 2022-08-22 핀치 테라퓨틱스 홀딩스 엘엘씨 분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
SG191145A1 (en) 2010-12-13 2013-07-31 Borody Thomas J Gastric and colonic formulations and methods for making and using them
EP2654735B1 (en) * 2010-12-22 2016-04-13 Basf Se Rapidly disintegrating, solid coated dosage form
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
CN103561752B (zh) 2011-03-09 2016-04-20 明尼苏达大学评议会 用于移植结肠微生物群的组合物和方法
JP6245786B2 (ja) * 2011-10-17 2017-12-13 大同化成工業株式会社 医薬用結合剤及び該結合剤を用いた製剤
IN2014DN07797A (pt) 2012-03-29 2015-05-15 Daicel Corp
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
EP3659598A1 (en) 2012-06-04 2020-06-03 Gaurav Agrawal Compositions and methods for treating crohn's disease and related conditions and infections
WO2014016671A2 (en) 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
US10292934B2 (en) 2012-09-20 2019-05-21 Daicel Corporation Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition
ITMI20121628A1 (it) * 2012-09-28 2014-03-29 Pharmafilm Srl Film orodisperdibili autosupportanti a rapida dissoluzione per uso terapeutico o alimentare
CN105307654B (zh) 2013-04-30 2022-06-07 托马斯·朱利叶斯·波洛迪 用于治疗微生物区系相关的精神病况和疾病的组合物和方法
JP6476122B2 (ja) * 2013-09-27 2019-02-27 株式会社ダイセル 二段階の湿式造粒工程で製造される崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
AU2015251692B2 (en) 2014-04-21 2019-12-19 Daicel Corporation Disintegrating particle composition including microfibrous cellulose
US10463620B2 (en) * 2014-10-16 2019-11-05 Cargill, Incorporated Process for preparing a directly compressible erythritol and uses thereof
CA2985827A1 (en) 2015-05-14 2016-11-17 Crestovo Holdings Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
NZ776366A (en) 2015-05-22 2023-02-24 Univ Minnesota Methods for treating autism spectrum disorder and associated symptoms
WO2017053327A1 (en) 2015-09-24 2017-03-30 San Diego State University (Sdsu) Foundation , Dba San Diego State University Research Foundation Antibacterial and protective bacteriophage formulations and methods for making and using them
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CA3058818A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating parkinson's disease (pd) and related disorders
CA3064773A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CA3072032A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CA3114423A1 (en) 2018-09-27 2020-04-02 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders
EP4268815A3 (en) * 2019-04-17 2024-02-21 NordicCan A/S Fast disintegrating cannabinoid tablets
US11633351B2 (en) * 2019-12-13 2023-04-25 Nordiccan A/S Fast disintegrating cannabinoid tablets
CA3147629A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
US11179331B1 (en) * 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3434138A1 (de) 1984-09-18 1986-03-27 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von unloeslichen, nur wenig quellbaren pulverfoermigen polymerisaten
US5569469A (en) 1984-10-16 1996-10-29 Vectorpharma International, S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
GB8518301D0 (en) 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
IL115445A (en) 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
US5879342A (en) 1996-10-21 1999-03-09 Kelley; Gregory S. Flexible and reinforced tubing
EP0839526A3 (en) 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
JP2001504342A (ja) * 1996-11-15 2001-04-03 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 成形されたまたは未成形のポリオール材料の製造方法
DE19709663A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
US5874418A (en) 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
KR100536783B1 (ko) * 1998-07-28 2005-12-14 다케다 야쿠힌 고교 가부시키가이샤 급속 붕해성 고체 제제
DE19912031A1 (de) 1999-03-17 2000-09-21 Basf Ag Verwendung von quervernetztem Polyvinylpyrrolidon zur Erhöhung der Zerfallgeschwindigkeit von kompakten teilchenförmigen Wasch- und Reinigungsmitteln
US20020071864A1 (en) * 1999-03-25 2002-06-13 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6495177B1 (en) 1999-08-13 2002-12-17 Warner Chilcott Laboratories Ireland Limited Orally dissolvable nutritional supplement
DE10011137A1 (de) 2000-03-10 2001-09-13 Basf Ag Verfahren zur Einstellung der Teilchengröße von Popcornpolymeren während der Popcornpolymerisation
US20020147232A1 (en) * 2000-05-26 2002-10-10 Claus Sundgreen Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU2002221939A1 (en) 2000-12-07 2002-06-18 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Rapidly disintegrating tablet comprising an acid-labile active ingredient
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US20020127277A1 (en) 2000-12-22 2002-09-12 Yihong Qiu Solid dosage forms of divalproex sodium
PL369298A1 (en) * 2001-09-26 2005-04-18 Pharmacia Corporation Intraorally disintegrating valdecoxib compositions
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
AU2002347182A1 (en) 2001-12-18 2003-06-30 Mondobiotech Licensing Out Ag Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
PL208114B1 (pl) * 2002-02-26 2011-03-31 Astrazeneca Ab Kompozycja farmaceutyczna, sposób jej wytwarzania i zastosowanie
GB0204771D0 (en) 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
JP2004026521A (ja) 2002-06-21 2004-01-29 Mitsubishi Chemicals Corp フラーレンの製造設備及びフラーレンの製造方法
AU2003291457A1 (en) 2002-11-08 2004-06-03 Glaxo Group Limited Pharmaceutical antiviral compositions
JP2006517929A (ja) * 2003-02-19 2006-08-03 ハー・ルンドベック・アクチエゼルスカベット 溶融アグロメレーションを用いてアグロメレートを製造する方法
JP2004265216A (ja) 2003-03-03 2004-09-24 Seiko Epson Corp 印刷装置、受信装置、中継装置、印刷システムおよび印刷方法
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
US20050244343A1 (en) 2004-04-30 2005-11-03 Withiam Michael C Oral care products comprising silica
US20050244492A1 (en) * 2004-04-30 2005-11-03 Mehra Dev K Rapidly disintegrating tablets comprising titanium dioxide
JP2006076971A (ja) 2004-09-13 2006-03-23 Basf Ag 口腔内崩壊錠
JP4446177B2 (ja) 2005-01-21 2010-04-07 東和薬品株式会社 耐湿性口腔内崩壊錠の製造方法
US8425935B2 (en) 2005-12-21 2013-04-23 Basf Se Pharmaceutical formulation for producing rapidly disintegrating tablets
JP5394746B2 (ja) * 2005-12-21 2014-01-22 ビーエーエスエフ ソシエタス・ヨーロピア 錠剤崩壊剤としての微粒子状架橋ポリビニルピロリドン
KR101903781B1 (ko) 2007-06-06 2018-11-13 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
WO2008148734A1 (de) 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von kau- und lutsch-tabletten
KR20100033400A (ko) 2007-06-06 2010-03-29 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
JP2010529071A (ja) 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性錠剤製造のための医薬製剤
DE102008038678B4 (de) * 2008-08-12 2012-03-08 Continental Automotive Gmbh Verfahren und Vorrichtung zum Schätzen einer Emission mindestens einer Abgaskomponente

Also Published As

Publication number Publication date
WO2008148742A3 (de) 2009-08-13
JP2010529074A (ja) 2010-08-26
AU2008258627A1 (en) 2008-12-11
JP5627455B2 (ja) 2014-11-19
KR20160083132A (ko) 2016-07-11
KR20100028624A (ko) 2010-03-12
CN101707930A (zh) 2010-05-12
JP2014114322A (ja) 2014-06-26
BRPI0812064B8 (pt) 2021-05-25
US20100178349A1 (en) 2010-07-15
KR101903781B1 (ko) 2018-11-13
CA2686964A1 (en) 2008-12-11
WO2008148742A2 (de) 2008-12-11
EP2164462A2 (de) 2010-03-24
CN101707930B (zh) 2013-10-30
US10406105B2 (en) 2019-09-10
BRPI0812064B1 (pt) 2019-08-13
MX2009013063A (es) 2010-01-15
ES2639130T3 (es) 2017-10-25
EP2164462B1 (de) 2017-05-31

Similar Documents

Publication Publication Date Title
BRPI0905717A2 (pt) Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
PT2799089T (pt) Processo para produzir uma formulação farmacêutica de agentes de contraste
BRPI0919192A2 (pt) Uso de lipídio, composição nutricional, e, processo para a produção de uma composição nutricional
BRPI0818541A2 (pt) Processo para a produção de um produto farmacêutico
BRPI0817423A2 (pt) Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto
BRPI1014865A2 (pt) "composição e formulação farmacêutica comreendendo derivados de nitrocatecol, e, método para fabricar uma composição ou formulação farmacêutica"
BRPI0920955A2 (pt) processo para a preparação de uma composição polimérica , composição polimérica, misturas, e, uso da composição polimérica
BRPI0915084A2 (pt) composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, métodos para a profilaxia ou tratamento de um estado de doença ou uma condição e de câncer
BRPI0815138A2 (pt) Métodos e organismos para a produção acoplada a crescimento de 1,4-butanodiol
BR112012000421A2 (pt) composições e métodos para intensificar a produção de um produto biológico.
BRPI1007161A2 (pt) composição farmacêutica oral, e processo para preparar uma composição
BRPI0815387A2 (pt) composição farmacêutica, método para fazer uma composição farmacêutica e método de tratar uma condição
PT2639223T (pt) Processos para produção de ácidos cicloalquilcarboxamido-piridinabenzoicos
FI20070569A0 (fi) Uusi stabiili tuote ja menetelmä sen valmistamiseksi
BRPI0905847A2 (pt) "composição farmacêutica injetável e processo para preparar a composição"
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BRPI0814821A2 (pt) Composto, composição farmacêutica, e, processo para preparar um composto
BR112012010007A2 (pt) processo para fabricação de uma composição biodegradável, composição biodegradável, artigo biodegradável e uso da composição
EP2116242A4 (en) NEW PHARMACEUTICAL COMPOSITION
BRPI0818781A2 (pt) Processo para a preparação de uma bebida fermentada
BR112012021066A2 (pt) processo de preparação de uma composição, composição e aplicação da composição
BRPI0807001A2 (pt) Formulação farmacêutica, e, método para preparação de uma formulação farmacêutica.
BRPI1008340A2 (pt) forma cristalina, composição farmacêutica, processos para fabricar uma composição farmacêutica e uma forma, uso da forma cristalina, e, método para tratar uma condição de doença

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/08/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/08/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/06/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22B Petition not considered [chapter 22.2 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 870210067135, DE 23/07/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI